Related Experiment Video
Updated: Aug 6, 2026

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
[Predicting and Preventing Alzheimer's Disease]
Maria-Christina Weber1, Jana Goedecke1, Gereon R Fink1
1Uniklinik Köln, Klinik und Poliklinik für Neurologie, Germany, Cologne.
Abstract:
Alzheimer's disease is a long-term biological process whose neuropathological changes begin decades before clinical symptoms appear. Advances in biomarker diagnostics enable the early identification of pathological changes and a more precise classification of different disease stages. Since therapeutic options have shown only limited effects so far, modifiable risk factors and preventive lifestyle interventions are increasingly coming into focus.
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Treatment
Dementia l: Introduction
Dementia
The progression of dementia is generally gradual.
